Cargando…

Effect of an L- and T-Type Calcium Channel Blocker on 24-Hour Systolic Blood Pressure and Heart Rate in Hypertensive Patients

BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the effects of an L- and T-type calcium channel blocker (CCB) on 24-hour systolic blood pressure (24-hour SBP) and heart rate (24-hour HR) profiles in essential hypertensive patients. SUBJECTS AND METHODS: Thirty-seven consecutive pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komukai, Masae, Tsutsumi, Takeshi, Ebado, Mio, Takeyama, Youichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341419/ https://www.ncbi.nlm.nih.gov/pubmed/22563335 http://dx.doi.org/10.4070/kcj.2012.42.4.231

Ejemplares similares

Indication-specific 6-hour systolic blood pressure thresholds can approximate 24-hour determination of blood pressure control
por: Ernst, Michael E., et al.
Publicado: (2010)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

In Silico Comparison Between Metoprolol Succinate and Bisoprolol on 24-Hour Systolic Blood Pressures
por: Jansson, Sven-Olof, et al.
Publicado: (2014)

24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes – a cross-sectional study
por: Theilade, Simone, et al.
Publicado: (2013)

Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination
por: Parati, Gianfranco, et al.
Publicado: (2018)

Reduction of blood pressure by store‐operated calcium channel blockers
por: Xu, Yan‐Jun, et al.
Publicado: (2015)

Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report
por: Hirakawa, Kyoko, et al.
Publicado: (2022)

Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates With Outcome
por: Mistry, Eva A., et al.
Publicado: (2017)

Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology
por: Kato, Hideki, et al.
Publicado: (2014)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: A systematic review and meta-analysis
por: Lin, Yu, et al.
Publicado: (2018)

Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension
por: Peng, Chi, et al.
Publicado: (2021)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
por: Kawabata, Yutaka, et al.
Publicado: (2020)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Effect of Topical Calcium Channel Blockers on Intraocular Pressure in Steroid-induced Glaucoma
por: Ganekal, Sunil, et al.
Publicado: (2014)

Beneficial Effect of Efonidipine, an L- and T-Type Dual Calcium Channel Blocker, on Heart Rate and Blood Pressure in Patients With Mild-to-Moderate Essential Hypertension
por: Oh, Il-Young, et al.
Publicado: (2010)

Is spontaneous normalization of systolic blood pressure within 24 hours after ischemic stroke onset related with favorable outcomes?
por: Kim, Seo Hyun, et al.
Publicado: (2019)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus
por: Nishida, Yayoi, et al.
Publicado: (2017)

Precise and ultrarapid control of blood pressure with clevidipine, an arterial selective calcium channel blocker
por: Varon, J, et al.
Publicado: (2007)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
por: Rubio-Guerra, Alberto F, et al.
Publicado: (2009)

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension
por: Wu, Yan, et al.
Publicado: (2022)

The Long-Term Response to Treatment with Calcium Channel Blockers in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Kiani, Azam, et al.
Publicado: (2023)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2012)

Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension
por: Shiga, Yuhei, et al.
Publicado: (2017)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pl6lvv95pii0g8m44bk6l5vlvl